The global Seasonal Influenza Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
GSK
Siobp
CCBIO
Sinovac
Lanzhou Institute Of Biological Product
Changsheng
Tianyuan Bio-Pharma
Sanofi
Aleph Biomedical
Hualan Bio
Tasly&Jenner
Vaxtec
Tiantan
Novartis
Hissen
Abbott
By Types:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other
By Applications:
Children
Adults
Elderly
Pregnancy
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Seasonal Influenza Vaccine Market Size Analysis from 2023 to 2028
1.5.1 Global Seasonal Influenza Vaccine Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Seasonal Influenza Vaccine Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Seasonal Influenza Vaccine Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Seasonal Influenza Vaccine Industry Impact
Chapter 2 Global Seasonal Influenza Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Seasonal Influenza Vaccine (Volume and Value) by Type
2.1.1 Global Seasonal Influenza Vaccine Consumption and Market Share by Type (2017-2022)
2.1.2 Global Seasonal Influenza Vaccine Revenue and Market Share by Type (2017-2022)
2.2 Global Seasonal Influenza Vaccine (Volume and Value) by Application
2.2.1 Global Seasonal Influenza Vaccine Consumption and Market Share by Application (2017-2022)
2.2.2 Global Seasonal Influenza Vaccine Revenue and Market Share by Application (2017-2022)
2.3 Global Seasonal Influenza Vaccine (Volume and Value) by Regions
2.3.1 Global Seasonal Influenza Vaccine Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Seasonal Influenza Vaccine Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Seasonal Influenza Vaccine Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Seasonal Influenza Vaccine Consumption by Regions (2017-2022)
4.2 North America Seasonal Influenza Vaccine Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Seasonal Influenza Vaccine Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Seasonal Influenza Vaccine Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Seasonal Influenza Vaccine Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Seasonal Influenza Vaccine Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Seasonal Influenza Vaccine Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Seasonal Influenza Vaccine Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Seasonal Influenza Vaccine Sales, Consumption, Export, Import (2017-2022)
4.10 South America Seasonal Influenza Vaccine Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Seasonal Influenza Vaccine Market Analysis
5.1 North America Seasonal Influenza Vaccine Consumption and Value Analysis
5.1.1 North America Seasonal Influenza Vaccine Market Under COVID-19
5.2 North America Seasonal Influenza Vaccine Consumption Volume by Types
5.3 North America Seasonal Influenza Vaccine Consumption Structure by Application
5.4 North America Seasonal Influenza Vaccine Consumption by Top Countries
5.4.1 United States Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
5.4.2 Canada Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
5.4.3 Mexico Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
Chapter 6 East Asia Seasonal Influenza Vaccine Market Analysis
6.1 East Asia Seasonal Influenza Vaccine Consumption and Value Analysis
6.1.1 East Asia Seasonal Influenza Vaccine Market Under COVID-19
6.2 East Asia Seasonal Influenza Vaccine Consumption Volume by Types
6.3 East Asia Seasonal Influenza Vaccine Consumption Structure by Application
6.4 East Asia Seasonal Influenza Vaccine Consumption by Top Countries
6.4.1 China Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
6.4.2 Japan Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
6.4.3 South Korea Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
Chapter 7 Europe Seasonal Influenza Vaccine Market Analysis
7.1 Europe Seasonal Influenza Vaccine Consumption and Value Analysis
7.1.1 Europe Seasonal Influenza Vaccine Market Under COVID-19
7.2 Europe Seasonal Influenza Vaccine Consumption Volume by Types
7.3 Europe Seasonal Influenza Vaccine Consumption Structure by Application
7.4 Europe Seasonal Influenza Vaccine Consumption by Top Countries
7.4.1 Germany Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
7.4.2 UK Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
7.4.3 France Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
7.4.4 Italy Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
7.4.5 Russia Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
7.4.6 Spain Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
7.4.7 Netherlands Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
7.4.8 Switzerland Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
7.4.9 Poland Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
Chapter 8 South Asia Seasonal Influenza Vaccine Market Analysis
8.1 South Asia Seasonal Influenza Vaccine Consumption and Value Analysis
8.1.1 South Asia Seasonal Influenza Vaccine Market Under COVID-19
8.2 South Asia Seasonal Influenza Vaccine Consumption Volume by Types
8.3 South Asia Seasonal Influenza Vaccine Consumption Structure by Application
8.4 South Asia Seasonal Influenza Vaccine Consumption by Top Countries
8.4.1 India Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
8.4.2 Pakistan Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Seasonal Influenza Vaccine Market Analysis
9.1 Southeast Asia Seasonal Influenza Vaccine Consumption and Value Analysis
9.1.1 Southeast Asia Seasonal Influenza Vaccine Market Under COVID-19
9.2 Southeast Asia Seasonal Influenza Vaccine Consumption Volume by Types
9.3 Southeast Asia Seasonal Influenza Vaccine Consumption Structure by Application
9.4 Southeast Asia Seasonal Influenza Vaccine Consumption by Top Countries
9.4.1 Indonesia Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
9.4.2 Thailand Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
9.4.3 Singapore Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
9.4.4 Malaysia Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
9.4.5 Philippines Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
9.4.6 Vietnam Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
9.4.7 Myanmar Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
Chapter 10 Middle East Seasonal Influenza Vaccine Market Analysis
10.1 Middle East Seasonal Influenza Vaccine Consumption and Value Analysis
10.1.1 Middle East Seasonal Influenza Vaccine Market Under COVID-19
10.2 Middle East Seasonal Influenza Vaccine Consumption Volume by Types
10.3 Middle East Seasonal Influenza Vaccine Consumption Structure by Application
10.4 Middle East Seasonal Influenza Vaccine Consumption by Top Countries
10.4.1 Turkey Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
10.4.3 Iran Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
10.4.5 Israel Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
10.4.6 Iraq Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
10.4.7 Qatar Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
10.4.8 Kuwait Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
10.4.9 Oman Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
Chapter 11 Africa Seasonal Influenza Vaccine Market Analysis
11.1 Africa Seasonal Influenza Vaccine Consumption and Value Analysis
11.1.1 Africa Seasonal Influenza Vaccine Market Under COVID-19
11.2 Africa Seasonal Influenza Vaccine Consumption Volume by Types
11.3 Africa Seasonal Influenza Vaccine Consumption Structure by Application
11.4 Africa Seasonal Influenza Vaccine Consumption by Top Countries
11.4.1 Nigeria Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
11.4.2 South Africa Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
11.4.3 Egypt Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
11.4.4 Algeria Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
11.4.5 Morocco Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
Chapter 12 Oceania Seasonal Influenza Vaccine Market Analysis
12.1 Oceania Seasonal Influenza Vaccine Consumption and Value Analysis
12.2 Oceania Seasonal Influenza Vaccine Consumption Volume by Types
12.3 Oceania Seasonal Influenza Vaccine Consumption Structure by Application
12.4 Oceania Seasonal Influenza Vaccine Consumption by Top Countries
12.4.1 Australia Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
12.4.2 New Zealand Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
Chapter 13 South America Seasonal Influenza Vaccine Market Analysis
13.1 South America Seasonal Influenza Vaccine Consumption and Value Analysis
13.1.1 South America Seasonal Influenza Vaccine Market Under COVID-19
13.2 South America Seasonal Influenza Vaccine Consumption Volume by Types
13.3 South America Seasonal Influenza Vaccine Consumption Structure by Application
13.4 South America Seasonal Influenza Vaccine Consumption Volume by Major Countries
13.4.1 Brazil Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
13.4.2 Argentina Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
13.4.3 Columbia Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
13.4.4 Chile Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
13.4.5 Venezuela Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
13.4.6 Peru Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
13.4.8 Ecuador Seasonal Influenza Vaccine Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Seasonal Influenza Vaccine Business
14.1 GSK
14.1.1 GSK Company Profile
14.1.2 GSK Seasonal Influenza Vaccine Product Specification
14.1.3 GSK Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Siobp
14.2.1 Siobp Company Profile
14.2.2 Siobp Seasonal Influenza Vaccine Product Specification
14.2.3 Siobp Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 CCBIO
14.3.1 CCBIO Company Profile
14.3.2 CCBIO Seasonal Influenza Vaccine Product Specification
14.3.3 CCBIO Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Sinovac
14.4.1 Sinovac Company Profile
14.4.2 Sinovac Seasonal Influenza Vaccine Product Specification
14.4.3 Sinovac Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Lanzhou Institute Of Biological Product
14.5.1 Lanzhou Institute Of Biological Product Company Profile
14.5.2 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Product Specification
14.5.3 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Changsheng
14.6.1 Changsheng Company Profile
14.6.2 Changsheng Seasonal Influenza Vaccine Product Specification
14.6.3 Changsheng Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Tianyuan Bio-Pharma
14.7.1 Tianyuan Bio-Pharma Company Profile
14.7.2 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Product Specification
14.7.3 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Sanofi
14.8.1 Sanofi Company Profile
14.8.2 Sanofi Seasonal Influenza Vaccine Product Specification
14.8.3 Sanofi Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Aleph Biomedical
14.9.1 Aleph Biomedical Company Profile
14.9.2 Aleph Biomedical Seasonal Influenza Vaccine Product Specification
14.9.3 Aleph Biomedical Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Hualan Bio
14.10.1 Hualan Bio Company Profile
14.10.2 Hualan Bio Seasonal Influenza Vaccine Product Specification
14.10.3 Hualan Bio Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Tasly&Jenner
14.11.1 Tasly&Jenner Company Profile
14.11.2 Tasly&Jenner Seasonal Influenza Vaccine Product Specification
14.11.3 Tasly&Jenner Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Vaxtec
14.12.1 Vaxtec Company Profile
14.12.2 Vaxtec Seasonal Influenza Vaccine Product Specification
14.12.3 Vaxtec Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Tiantan
14.13.1 Tiantan Company Profile
14.13.2 Tiantan Seasonal Influenza Vaccine Product Specification
14.13.3 Tiantan Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Novartis
14.14.1 Novartis Company Profile
14.14.2 Novartis Seasonal Influenza Vaccine Product Specification
14.14.3 Novartis Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Hissen
14.15.1 Hissen Company Profile
14.15.2 Hissen Seasonal Influenza Vaccine Product Specification
14.15.3 Hissen Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Abbott
14.16.1 Abbott Company Profile
14.16.2 Abbott Seasonal Influenza Vaccine Product Specification
14.16.3 Abbott Seasonal Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Seasonal Influenza Vaccine Market Forecast (2023-2028)
15.1 Global Seasonal Influenza Vaccine Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Seasonal Influenza Vaccine Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Seasonal Influenza Vaccine Value and Growth Rate Forecast (2023-2028)
15.2 Global Seasonal Influenza Vaccine Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Seasonal Influenza Vaccine Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Seasonal Influenza Vaccine Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Seasonal Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Seasonal Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Seasonal Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Seasonal Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Seasonal Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Seasonal Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Seasonal Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Seasonal Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Seasonal Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Seasonal Influenza Vaccine Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Seasonal Influenza Vaccine Consumption Forecast by Type (2023-2028)
15.3.2 Global Seasonal Influenza Vaccine Revenue Forecast by Type (2023-2028)
15.3.3 Global Seasonal Influenza Vaccine Price Forecast by Type (2023-2028)
15.4 Global Seasonal Influenza Vaccine Consumption Volume Forecast by Application (2023-2028)
15.5 Seasonal Influenza Vaccine Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 129 |
| Price : US$ 2450 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 269 |
Request Sample 
Request Discount 
Inquire Before Buy
